Postepy Dermatol Alergol. 2014 Oct;31(5):294-8. doi: 10.5114/pdia.2014.44019. Epub 2014 Oct 22.
Triggering drug use in patients with psoriasis: an investigative report from Turkey.
Postepy dermatologii i alergologii
Zerrin Ogretmen, Ulku Askin, Meliha Merve Hiz, Sibel Cevizci
Affiliations
Affiliations
- Department of Dermatology, School of Medicine, Çanakkale Onsekiz Mart University, Canakkale, Turkey. Head of Department: Prof. Zerrin Ö?retmen MD.
- Department of Dermatology, Baskent University Zübeyde Han?m Training and Research Center, Izmir, Turkey. Head of Department: Prof. Tülin Güleç MD.
- Department of Biology, The Faculty of Arts and Sciences, Canakkale Onsekiz Mart University, Canakkale, Turkey. Head of Department: Prof. ?smet Uysal PhD.
- Department of Public Health, School of Medicine, Canakkale Onsekiz Mart University, Canakkale, Turkey. Head of Department: Assoc. Prof. Ço?kun Bakar MD.
PMID: 25395925
PMCID: PMC4221355 DOI: 10.5114/pdia.2014.44019
Abstract
INTRODUCTION: The patients clinically diagnosed with psoriasis were investigated for drug use that may trigger psoriasis.
AIM: To minimize the triggering drug use and help the medical treatment of psoriasis patients.
MATERIAL AND METHODS: The study involved 289 psoriatic patients who attended our clinic in 2010-2012 and were asked to bring their drug lists of the last year, which they obtained from the pharmacy's record system. They were advised not to use the drugs that may trigger psoriasis. Data analyses were performed using SPSS program version 19.0.
RESULTS: A total of 289 patients were included in the study. Two hundred and twenty-one patients were using non-steroidal anti-inflammatory drugs; 133 patients were using anti-reflux drugs; 35 patients were using antidiabetic drugs; 31 patients were using calcium-channel blockers and 24 patients were using β-blockers. In our study group, there was no significantly difference between median PASI scores of the patients using a triggering drug and those of who are not using a triggering drug. However, there was a positive low correlation between PASI rates and numbers of drugs used (r = 0.180, p = 0.013).
CONCLUSIONS: Many other factors may trigger psoriasis, therefore the effect of stopping or minimizing the drug use on disease remission is not known. Because of the high triggering drug use rate, it is important to enlighten psoriasis patients about triggering drugs.
Keywords: non-steroidal anti-inflammatory drugs; psoriasis; triggering drugs; β-blockers
References
- Diabetologia. 2011 Nov;54(11):2745-54 - PubMed
- Eur J Dermatol. 1998 Dec;8(8):563-8 - PubMed
- Clin Exp Rheumatol. 2010 May-Jun;28(3):408-10 - PubMed
- Am J Ther. 2011 May;18(3):e78-80 - PubMed
- J Am Acad Dermatol. 1988 Oct;19(4):629-32 - PubMed
- Tijdschr Psychiatr. 2012;54(3):285-9 - PubMed
- Arch Dermatol. 1988 Jun;124(6):854-5 - PubMed
- Acta Derm Venereol. 2001 Oct-Nov;81(5):347-9 - PubMed
- Skin Therapy Lett. 2011 Apr;16(4):5-6 - PubMed
- Acta Dermatovenerol Croat. 2003;11(1):17-21 - PubMed
- J Clin Pharm Ther. 2008 Jun;33(3):321-5 - PubMed
- J Dermatolog Treat. 2009;20(2):100-8 - PubMed
- Ugeskr Laeger. 1991 Jan 7;153(2):132 - PubMed
- J Clin Psychopharmacol. 2009 Apr;29(2):134-40 - PubMed
- Ann Dermatol Venereol. 2000 Mar;127(3):279-81 - PubMed
- Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):446.e9-446.e10 - PubMed
- Cutis. 1979 Jul;24(1):95-8 - PubMed
- J Dermatol. 1993 May;20(5):279-86 - PubMed
- J Am Acad Dermatol. 1997 Jun;36(6 Pt 1):932-4 - PubMed
- J Am Acad Dermatol. 1987 Nov;17(5 Pt 2):918-20 - PubMed
- CMAJ. 2009 Jul 7;181(1-2):60 - PubMed
- Am J Clin Dermatol. 2000 May-Jun;1(3):159-65 - PubMed
- J Clin Aesthet Dermatol. 2010 Jan;3(1):32-8 - PubMed
- Dermatol Online J. 2003 Aug;9(3):11 - PubMed
- Harefuah. 1994 Oct;127(7-8):228-9, 287 - PubMed
- Int J Dermatol. 2010 Dec;49(12):1351-61 - PubMed
- Dermatologica. 1982 Sep;165(3):197-203 - PubMed
- Ugeskr Laeger. 1997 Jan 27;159(5):598-600 - PubMed
- Clin Rheumatol. 1991 Jun;10(2):178-80 - PubMed
- Semin Dermatol. 1992 Dec;11(4):269-74 - PubMed
- Acta Derm Venereol. 1984;64(4):346-8 - PubMed
- J Hepatol. 2010 Sep;53(3):587 - PubMed
- Br J Dermatol. 2004 May;150(5):966-9 - PubMed
- J Rheumatol Suppl. 2009 Aug;83:59-61 - PubMed
- Actas Esp Psiquiatr. 2002 Nov-Dec;30(6):400-3 - PubMed
- Prim Care Companion J Clin Psychiatry. 2008;10(6):435-9 - PubMed
- Cutis. 1986 Jul;38(1):45 - PubMed
- J Am Acad Dermatol. 1994 Jun;30(6):1045 - PubMed
- J Drugs Dermatol. 2006 May;5(5):426-32 - PubMed
- Gastroenterol Hepatol. 2011 Oct;34(8):546-50 - PubMed
- J Am Acad Dermatol. 1997 May;36(5 Pt 2):858-62 - PubMed
- Australas J Dermatol. 2012 Feb;53(1):70-2 - PubMed
- N Z Med J. 1993 Sep 8;106(963):392-3 - PubMed
- Eur J Dermatol. 2003 Jul-Aug;13(4):404-5 - PubMed
- J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):1007-22 - PubMed
- Clin Dermatol. 2007 Nov-Dec;25(6):606-15 - PubMed
- Adv Exp Med Biol. 1999;455:221-5 - PubMed
- Ann Pharmacother. 1992 Feb;26(2):211-2 - PubMed
Publication Types